Hosted on MSN11mon
MHRA approves TMC Pharma’s fosdenopterin for MoCD type AThe UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved TMC Pharma's fosdenopterin (Nulibry) for the treatment of molybdenum cofactor deficiency (MoCD) type A. This rare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback